Study to Evaluate Safety and Efficacy of PF-06700841 in Subjects with Moderate to Severe Plaque Psoriasis

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of PF-06700841 in Subjects with Moderate to Severe Plaque Psoriasis

Category & Conditions:
Skin Diseases and Conditions
Medicine:
PF-06700841
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7931004
Open Plain Language Summary Result:Click here